(Q43883698)

27 November 2017

Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemia (English)

1 reference

27 November 2017

1 reference

Stephen B Marley

1

1 reference

27 November 2017

R John Davidson

series ordinal

2

1 reference

27 November 2017

John M Goldman

series ordinal

3

1 reference

27 November 2017

Myrtle Y Gordon

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

British Journal of Haematology

27 November 2017

1 reference

27 November 2017

116

1 reference

27 November 2017

162-165

1 reference

27 November 2017

1

1 reference

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

27 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03237.X

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03237.X

Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03237.X

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03237.X

Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03237.X

Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03237.X

10.1046/J.1365-2141.2002.03237.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference